UniProt ID | OGFR_HUMAN | |
---|---|---|
UniProt AC | Q9NZT2 | |
Protein Name | Opioid growth factor receptor | |
Gene Name | OGFR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 677 | |
Subcellular Localization | Cytoplasm. Nucleus. The OGF/OGFR complex is probably translocated to the nucleus. | |
Protein Description | Receptor for opioid growth factor (OGF), also known as Met-enkephalin. Seems to be involved in growth regulation.. | |
Protein Sequence | MDDPDCDSTWEEDEEDAEDAEDEDCEDGEAAGARDADAGDEDEESEEPRAARPSSFQSRMTGSRNWRATRDMCRYRHNYPDLVERDCNGDTPNLSFYRNEIRFLPNGCFIEDILQNWTDNYDLLEDNHSYIQWLFPLREPGVNWHAKPLTLREVEVFKSSQEIQERLVRAYELMLGFYGIRLEDRGTGTVGRAQNYQKRFQNLNWRSHNNLRITRILKSLGELGLEHFQAPLVRFFLEETLVRRELPGVRQSALDYFMFAVRCRHQRRQLVHFAWEHFRPRCKFVWGPQDKLRRFKPSSLPHPLEGSRKVEEEGSPGDPDHEASTQGRTCGPEHSKGGGRVDEGPQPRSVEPQDAGPLERSQGDEAGGHGEDRPEPLSPKESKKRKLELSRREQPPTEPGPQSASEVEKIALNLEGCALSQGSLRTGTQEVGGQDPGEAVQPCRQPLGARVADKVRKRRKVDEGAGDSAAVASGGAQTLALAGSPAPSGHPKAGHSENGVEEDTEGRTGPKEGTPGSPSETPGPSPAGPAGDEPAESPSETPGPRPAGPAGDEPAESPSETPGPRPAGPAGDEPAESPSETPGPSPAGPTRDEPAESPSETPGPRPAGPAGDEPAESPSETPGPRPAGPAGDEPAESPSETPGPSPAGPTRDEPAKAGEAAELQDAEVESSAKSGKP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDDPDCDS -------CCCCCCCC | 13.72 | 19413330 | |
8 | Phosphorylation | MDDPDCDSTWEEDEE CCCCCCCCCCCCCHH | 41.57 | 26552605 | |
9 | Phosphorylation | DDPDCDSTWEEDEED CCCCCCCCCCCCHHH | 24.52 | 26552605 | |
45 | Phosphorylation | AGDEDEESEEPRAAR CCCCCCCCCCCCCCC | 45.25 | 20873877 | |
54 | Phosphorylation | EPRAARPSSFQSRMT CCCCCCCCHHHHHHH | 37.93 | 26434776 | |
55 | Phosphorylation | PRAARPSSFQSRMTG CCCCCCCHHHHHHHC | 29.95 | 25106551 | |
58 | Phosphorylation | ARPSSFQSRMTGSRN CCCCHHHHHHHCCCC | 23.24 | 26434776 | |
158 (in isoform 2) | Ubiquitination | - | 55.14 | 21890473 | |
158 (in isoform 1) | Ubiquitination | - | 55.14 | 21890473 | |
158 | Ubiquitination | LREVEVFKSSQEIQE EEEEEEHHCCHHHHH | 55.14 | 21906983 | |
171 | Phosphorylation | QERLVRAYELMLGFY HHHHHHHHHHHHHHH | 10.07 | 22817900 | |
178 | Phosphorylation | YELMLGFYGIRLEDR HHHHHHHHCEEEECC | 15.16 | 22817900 | |
187 | Phosphorylation | IRLEDRGTGTVGRAQ EEEECCCCCCHHCHH | 30.49 | - | |
189 | Phosphorylation | LEDRGTGTVGRAQNY EECCCCCCHHCHHHH | 21.45 | - | |
196 | Phosphorylation | TVGRAQNYQKRFQNL CHHCHHHHHHHHHHC | 11.88 | 22817900 | |
198 | Ubiquitination | GRAQNYQKRFQNLNW HCHHHHHHHHHHCCC | 44.83 | 27667366 | |
218 (in isoform 2) | Ubiquitination | - | 41.06 | 21890473 | |
218 | Ubiquitination | LRITRILKSLGELGL HHHHHHHHHHHHHCH | 41.06 | 23000965 | |
218 (in isoform 1) | Ubiquitination | - | 41.06 | 21890473 | |
240 | Phosphorylation | VRFFLEETLVRRELP HHHHHHHHHHHHCCC | 22.60 | 25599653 | |
252 | Phosphorylation | ELPGVRQSALDYFMF CCCCCHHHHHHHHHH | 21.89 | 24043423 | |
256 | Phosphorylation | VRQSALDYFMFAVRC CHHHHHHHHHHHHHC | 9.59 | 24043423 | |
283 | Ubiquitination | EHFRPRCKFVWGPQD HHHHCCCEEEECCHH | 44.20 | - | |
283 | Acetylation | EHFRPRCKFVWGPQD HHHHCCCEEEECCHH | 44.20 | 25953088 | |
291 | Ubiquitination | FVWGPQDKLRRFKPS EEECCHHHHHCCCCC | 38.35 | 21963094 | |
291 (in isoform 1) | Ubiquitination | - | 38.35 | 21890473 | |
291 (in isoform 2) | Ubiquitination | - | 38.35 | 21890473 | |
291 | Acetylation | FVWGPQDKLRRFKPS EEECCHHHHHCCCCC | 38.35 | 21339330 | |
296 | Ubiquitination | QDKLRRFKPSSLPHP HHHHHCCCCCCCCCC | 42.02 | 22817900 | |
298 | Phosphorylation | KLRRFKPSSLPHPLE HHHCCCCCCCCCCCC | 45.13 | 23401153 | |
299 | Phosphorylation | LRRFKPSSLPHPLEG HHCCCCCCCCCCCCC | 55.22 | 20873877 | |
307 | Phosphorylation | LPHPLEGSRKVEEEG CCCCCCCCCCCCCCC | 21.39 | 23186163 | |
309 | Sumoylation | HPLEGSRKVEEEGSP CCCCCCCCCCCCCCC | 56.55 | - | |
309 | Sumoylation | HPLEGSRKVEEEGSP CCCCCCCCCCCCCCC | 56.55 | - | |
309 | Ubiquitination | HPLEGSRKVEEEGSP CCCCCCCCCCCCCCC | 56.55 | 24816145 | |
315 | Phosphorylation | RKVEEEGSPGDPDHE CCCCCCCCCCCCCCC | 29.05 | 29255136 | |
324 | Phosphorylation | GDPDHEASTQGRTCG CCCCCCHHCCCCCCC | 20.48 | 23927012 | |
325 | Phosphorylation | DPDHEASTQGRTCGP CCCCCHHCCCCCCCC | 41.93 | 23927012 | |
329 | Phosphorylation | EASTQGRTCGPEHSK CHHCCCCCCCCCCCC | 28.74 | - | |
335 | Phosphorylation | RTCGPEHSKGGGRVD CCCCCCCCCCCCCCC | 31.19 | 20860994 | |
349 | Phosphorylation | DEGPQPRSVEPQDAG CCCCCCCCCCCCCCC | 37.20 | 29255136 | |
361 | Phosphorylation | DAGPLERSQGDEAGG CCCCCCHHCCCCCCC | 29.19 | 30266825 | |
378 | Phosphorylation | EDRPEPLSPKESKKR CCCCCCCCHHHHHHH | 44.64 | 29255136 | |
382 | Phosphorylation | EPLSPKESKKRKLEL CCCCHHHHHHHHHHH | 49.99 | 23401153 | |
384 | Ubiquitination | LSPKESKKRKLELSR CCHHHHHHHHHHHHH | 65.13 | 24816145 | |
386 | Ubiquitination | PKESKKRKLELSRRE HHHHHHHHHHHHHCC | 56.01 | 27667366 | |
390 | Phosphorylation | KKRKLELSRREQPPT HHHHHHHHHCCCCCC | 21.66 | 24117733 | |
397 | Phosphorylation | SRREQPPTEPGPQSA HHCCCCCCCCCCCCH | 62.59 | 29978859 | |
403 | Phosphorylation | PTEPGPQSASEVEKI CCCCCCCCHHHHHHH | 36.57 | 25159151 | |
405 | Phosphorylation | EPGPQSASEVEKIAL CCCCCCHHHHHHHHH | 47.63 | 25262027 | |
420 | Phosphorylation | NLEGCALSQGSLRTG CCCCHHHCCCCCCCC | 17.61 | 17525332 | |
423 | Phosphorylation | GCALSQGSLRTGTQE CHHHCCCCCCCCCCC | 13.67 | 28450419 | |
426 | Phosphorylation | LSQGSLRTGTQEVGG HCCCCCCCCCCCCCC | 50.29 | 22817900 | |
428 | Phosphorylation | QGSLRTGTQEVGGQD CCCCCCCCCCCCCCC | 22.42 | 22817900 | |
454 | Acetylation | LGARVADKVRKRRKV CCHHHHHHHHHHCCC | 33.91 | 30591015 | |
468 | Phosphorylation | VDEGAGDSAAVASGG CCCCCCCCHHHHCCC | 19.74 | 23927012 | |
473 | Phosphorylation | GDSAAVASGGAQTLA CCCHHHHCCCCCEEE | 31.03 | 30278072 | |
478 | Phosphorylation | VASGGAQTLALAGSP HHCCCCCEEEECCCC | 17.29 | 23927012 | |
484 | Phosphorylation | QTLALAGSPAPSGHP CEEEECCCCCCCCCC | 16.57 | 29255136 | |
488 | Phosphorylation | LAGSPAPSGHPKAGH ECCCCCCCCCCCCCC | 52.41 | 23401153 | |
496 | Phosphorylation | GHPKAGHSENGVEED CCCCCCCCCCCCCCC | 31.66 | 28985074 | |
508 | Phosphorylation | EEDTEGRTGPKEGTP CCCCCCCCCCCCCCC | 69.56 | 26074081 | |
514 | Phosphorylation | RTGPKEGTPGSPSET CCCCCCCCCCCCCCC | 26.10 | 30266825 | |
517 (in isoform 2) | Phosphorylation | - | 26.84 | 25137130 | |
517 | Phosphorylation | PKEGTPGSPSETPGP CCCCCCCCCCCCCCC | 26.84 | 19664994 | |
519 (in isoform 2) | Phosphorylation | - | 56.66 | 25137130 | |
519 | Phosphorylation | EGTPGSPSETPGPSP CCCCCCCCCCCCCCC | 56.66 | 30266825 | |
521 (in isoform 2) | Phosphorylation | - | 37.57 | 25137130 | |
521 | Phosphorylation | TPGSPSETPGPSPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
525 | Phosphorylation | PSETPGPSPAGPAGD CCCCCCCCCCCCCCC | 33.04 | 30266825 | |
525 (in isoform 2) | Phosphorylation | - | 33.04 | 25137130 | |
537 (in isoform 2) | Phosphorylation | - | 35.51 | 25137130 | |
537 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 19664994 | |
539 (in isoform 2) | Phosphorylation | - | 64.48 | 25137130 | |
539 | Phosphorylation | DEPAESPSETPGPRP CCCCCCCCCCCCCCC | 64.48 | 23401153 | |
541 (in isoform 2) | Phosphorylation | - | 37.57 | 25137130 | |
541 | Phosphorylation | PAESPSETPGPRPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
557 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 19664994 | |
557 (in isoform 2) | Phosphorylation | - | 35.51 | 25137130 | |
559 | Phosphorylation | DEPAESPSETPGPRP CCCCCCCCCCCCCCC | 64.48 | 30266825 | |
561 | Phosphorylation | PAESPSETPGPRPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
577 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 30266825 | |
579 | Phosphorylation | DEPAESPSETPGPSP CCCCCCCCCCCCCCC | 64.48 | 30266825 | |
581 | Phosphorylation | PAESPSETPGPSPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
585 | Phosphorylation | PSETPGPSPAGPTRD CCCCCCCCCCCCCCC | 33.04 | 30266825 | |
590 | Phosphorylation | GPSPAGPTRDEPAES CCCCCCCCCCCCCCC | 50.24 | 23663014 | |
597 | Phosphorylation | TRDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 23401153 | |
599 | Phosphorylation | DEPAESPSETPGPRP CCCCCCCCCCCCCCC | 64.48 | 23401153 | |
601 | Phosphorylation | PAESPSETPGPRPAG CCCCCCCCCCCCCCC | 37.57 | 23663014 | |
617 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 19664994 | |
619 | Phosphorylation | DEPAESPSETPGPRP CCCCCCCCCCCCCCC | 64.48 | 30266825 | |
621 | Phosphorylation | PAESPSETPGPRPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
636 (in isoform 2) | Ubiquitination | - | 74.11 | - | |
637 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 30266825 | |
639 | Phosphorylation | DEPAESPSETPGPSP CCCCCCCCCCCCCCC | 64.48 | 30266825 | |
641 | Phosphorylation | PAESPSETPGPSPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
645 | Phosphorylation | PSETPGPSPAGPTRD CCCCCCCCCCCCCCC | 33.04 | 30266825 | |
650 | Phosphorylation | GPSPAGPTRDEPAKA CCCCCCCCCCCCCCC | 50.24 | 29255136 | |
656 | Ubiquitination | PTRDEPAKAGEAAEL CCCCCCCCCCCHHHH | 68.58 | 23503661 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
378 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OGFR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OGFR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CDC37_HUMAN | CDC37 | physical | 22863883 | |
FKBP5_HUMAN | FKBP5 | physical | 22863883 | |
SHOT1_HUMAN | KIAA1598 | physical | 22863883 | |
MAGD2_HUMAN | MAGED2 | physical | 22863883 | |
TRAP1_HUMAN | TRAP1 | physical | 22863883 | |
UBP7_HUMAN | USP7 | physical | 22863883 | |
CDK4_HUMAN | CDK4 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-315, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-349 ANDSER-378, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-315, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349; SER-361; SER-378AND SER-484, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315 AND SER-378, ANDMASS SPECTROMETRY. |